63083-2084 NDC - ANTI-SCAR DROPS

Drug Information

Product NDC: 63083-2084

Proprietary Name: Anti-Scar Drops

Non Proprietary Name: Anti-Scar Drops

Active Ingredient(s):
  • 6 [hp_X]/59mL ACONITUM NAPELLUS WHOLE;
  • 6 [hp_X]/59mL ALLYLTHIOUREA;
  • 6 [hp_X]/59mL ANHYDROUS DIBASIC CALCIUM PHOSPHATE;
  • 100 [hp_X]/59mL ARNICA MONTANA WHOLE;
  • 12 [hp_X]/59mL GRAPHITE;
  • 60 [hp_X]/59mL LACTOSE, X-RAY EXPOSED (1000 RAD);
  • 8 [hp_X]/59mL NITRIC ACID;
  • 6 [hp_X]/59mL POTASSIUM ALUM;
  • 6 [hp_X]/59mL SILICON DIOXIDE;
  • 3 [hp_X]/59mL THUJA OCCIDENTALIS LEAF


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Labeler Information

Labeler Name: Professional Complementary Health Formulas
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:8/15/1984

Package Information

No. Package Code Package Description Billing Unit
163083-2084-259 mL in 1 BOTTLE, DROPPER (63083-2084-2)

NDC Record

Field Name Field Value Definition
PRODUCT NDC63083-2084The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEAnti-Scar DropsThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAME SUFFIX2084A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
NON PROPRIETARY NAMEAnti-Scar DropsThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE8/15/1984This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEProfessional Complementary Health FormulasName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEACONITUM NAPELLUS WHOLE; ALLYLTHIOUREA; ANHYDROUS DIBASIC CALCIUM PHOSPHATE; ARNICA MONTANA WHOLE; GRAPHITE; LACTOSE, X-RAY EXPOSED (1000 RAD); NITRIC ACID; POTASSIUM ALUM; SILICON DIOXIDE; THUJA OCCIDENTALIS LEAFAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH6; 6; 6; 100; 12; 60; 8; 6; 6; 3 
ACTIVE INGRED UNIT[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023